CLINICAL AND IMMUNOLOGICAL RELATIONSHIP BETWEEN COVID-19 AND RHEUMATOID ARTHRITIS
Keywords:
Key words: COVID-19, immune-inflammatory rheumatic diseases, diagnostics, cytokines.Abstract
Abstract: Rheumatoid arthritis is the most common inflammatory disease of the joints, characterized by erosive symmetrical polyarthritis in combination with systemic immune-inflammatory damage to internal organs. One of the most severe and widespread inflammatory diseases of the joints. Rheumatoid arthritis is a common disease, occurring in all countries in approximately 1% of the total population. New data have shown that respiratory viral infections may increase the risk of autoimmune inflammatory arthritis, such as rheumatoid arthritis. In addition, infections may worsen the disease in patients with inflammatory arthritis.
References
1. Belov B.S., Muravyova N.V., Tarasova G.M. COVID-19: rheumatological aspects // Effective pharmacotherapy. 2020. Т. 16. № 16. С. 18–25. DOI 10.33978/2307-3586-2020-16-16-18-25
2. Nasonov E.L. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: results and prospects. Scientific and practical rheumatology. 2024;62(1):32-54. https://doi.org/10.47360/1995-4484-2024-32-54
3. Belov B.S., Karateev A.E. COVID-19: a new challenge for rheumatologists. Modern Rheumatology. 2020;14(2):110-116. https://doi.org/10.14412/1996-7012-2020-2-110-116
4. Sokolova V.V., Lapin S.V., Moskalov A.V., Mazurov V.I. Clinical and immunological relationships in early rheumatoid arthritis. Medical Immunology. 2007;9(6):635-642. https://doi.org/10.15789/1563-0625-2007-6-635-642
5. Dibrov D.A. ACCP-negative rheumatoid arthritis — clinical and immunological features. Scientific and practical rheumatology. 2022;60(3):314-326. https://doi.org/10.47360/1995-4484-2022-314-326
6. G.G. Taradin, T.E. Kugler, I.S. Malovichko, L.V. Kononenko. Acute arthritis associated with COVID-19. Almanac of Clinical Medicine. 2022; 50 (2): 139–148. doi: 10.18786/2072-0505-2022-50-015.
7. Belov B.S., Muravyova NV, Tarasova GM. COVID-19 and rheumatology: so far, so close. Medical Council. 2020;(8):135-143. https://doi.org/10.21518/2079-701X-2020-8-135-143
8. Akhmedov H.S. Features of the immune status in rheumatoid arthritis depending on the climatic, geographical and ecological zones of Uzbekistan. Scientific and practical rheumatology. 2016;54(2):183-186. https://doi.org/10.14412/1995-4484-2016-183-186
9. M.F. Beketova, V.V. Babak, M.D. Suprun, T.V. Beketova, O.A. Georginova. On the issue of late complications of COVID-19 in patients with rheumatic diseases. Scientific and practical rheumatology. 2022;60(2):162–164.
10. Mazurov V.I., Belyaeva I.B., Sarantseva L.E., Chudinov A.L., Bashkinov R.A., Trofimov E.A., Smulskaya O.A., Inamova O.V., Petrova M.S., Melnikov E.S. The influence of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases // Bulletin of the North-West State Medical University named after I.I. Mechnikov. 2021. Т. 13. № 2. С. 39–47. DOI: https://doi.org/10.17816/mechnikov7226.
11. A.M. Kozodaeva. M.Sh. Shingarova. DEBUT OF JUVENILE RHEUMATOID ARTHRITIS AFTER CORONAVIRUS INFECTION. Russian pediatric journal (Russian journal). 2024; 27. Supplement 1 https://doi.org/10.46563/1560-9561-2024-27-S1
12. Korolev M.A., Letyagina E.A., Sizikov A.E., Bogoderova L.A., Ubshaeva Yu.B., Omelchenko V.O., Akimova A.A., Mullagaliev A.A., Chumasova O.A., Kurochkina Yu.D. Immunoinflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the registry of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs. Therapeutic archive. 2022;94(5):636–641. DOI: 10.26442/00403660.2022.05.201502.
